Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
The manufacture, sale, and distribution of chlorofluorocarbon-propelled albuterol metered-dose inhalers ceased as of December 31, 2008. Clinicians should actively transition patients to currently available hydrofluoroalkane-propelled devices, providing concise education and instruction for using the newer devices.
Section on Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. sppeters@wfubmc.edu
Stephen
S
Peters
D000335:Aerosol Propellants; D017402:Chlorofluorocarbons; D006801:Humans; D006845:Hydrocarbons, Fluorinated; D009330:Nebulizers and Vaporizers / Q000592:standards*; D010353:Patient Education as Topic; D005466:Fluorocarbons
D000335:Aerosol Propellants; D017402:Chlorofluorocarbons; D006845:Hydrocarbons, Fluorinated; C094049:apaflurane; D005466:Fluorocarbons